4.8 Editorial Material

Is silence still golden? Mapping the RNAi patent landscape

Related references

Note: Only part of the references are listed.
Editorial Material Biotechnology & Applied Microbiology

The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags

Bonnie W. McLeod et al.

NATURE BIOTECHNOLOGY (2011)

News Item Multidisciplinary Sciences

Drug giants turn their backs on RNA interference

Heidi Ledford

NATURE (2010)

News Item Biotechnology & Applied Microbiology

2009: Turning the corner

Walter Yang

NATURE BIOTECHNOLOGY (2010)

Editorial Material Biotechnology & Applied Microbiology

On firm ground: IP protection of therapeutic nanoparticles

Paul Burgess et al.

NATURE BIOTECHNOLOGY (2010)

News Item Multidisciplinary Sciences

DRUG RESEARCH Roche Exits RNAi Field, Cuts 4800 Jobs

Jennifer Couzin-Frankel

SCIENCE (2010)

Article Biotechnology & Applied Microbiology

Public biotech 2008-the numbers

Brady Huggett et al.

NATURE BIOTECHNOLOGY (2009)

News Item Biotechnology & Applied Microbiology

Teaming up to tackle RNAi delivery challenge

Dan Jones

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Biotechnology & Applied Microbiology

Public biotech 2006 -: the numbers

Riku Lahteenmaki et al.

NATURE BIOTECHNOLOGY (2007)

Article Multidisciplinary Sciences

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

SM Elbashir et al.

NATURE (2001)